Thanks, Mike. Our press release and Form 10-Q, which were filed yesterday provide extensive details of our financials, so I will focus on some key highlights. Focusing on the income statement. During the first quarter, the ODR segment accounted for 48.5% of total consolidated revenue. That compares with 44.6% in the fourth quarter of 2022 and 43.6% for the full year 2022. So we are continuing to make good progress towards reaching the 50-50 revenue split milestone with a long-term goal of our ODR segment, contributing 70% or more to total consolidated revenue. Consolidated gross margin during the first quarter was 21.7% as a result of both the increasing contribution from our higher-margin ODR segment and strong margin performance within each segment. For the quarter, GCR gross margin was 16.6% while ODR was 27.1%. So again, in our view, very good performance in both segments. Also to expand on Mike's comments regarding GCR margins. A year ago, we were talking about GCR gross margin in the 11% to 12% range, and we increased that to 12% to 15%. This is a result of continuing to not only focus on execution, but also the selection of projects. As a result, we expect to see margins fluctuate quarter-to-quarter depending on the timing of those newer projects as we have a mix of new, higher-margin projects and older, lower-margin projects in backlog. SG&A expense in the first quarter was $21.1 million, up from $18.7 million in the year ago period. The $2.3 million increase included approximately $811,000 of costs related to the CEO transition and $534,000 increase in stock-based compensation expense, primarily due to an increase in the grant date stock price year-over-year. On our last call, we noted that 2023 full year SG&A should have a similar run rate as a percentage of total revenue to 2022, and we continue to expect that to be the case. Also consistent with the prior year, we currently expect that our revenue in the second half of the year to be stronger than in the first half, which would cause SG&A expense to be a higher as a percentage of revenue in the first half of the year. Turning to cash flow. Solid execution and working capital management during the first quarter contributed to operating cash flow of $9.4 million. Changes in working capital accounts had a positive impact of $1.8 million on the operating cash flow. Accounts receivable provided cash of $24.6 million as a result of the decrease in AR from December 31. This included collecting $10 million from the claims settlement we talked about on last quarter's earnings call. And it was great to see that coming during the first quarter. Offsetting the increase was cash used in accounts payable of $14.9 million and accrued expenses of $3.2 million, which included payment of the 2022 accrued incentive compensation. The remaining $7.6 million of operating cash flow was a nonworking capital component. As we have noted previously, our free cash flow can be calculated by taking this figure and then subtracting CapEx which totaled $923,000 in the quarter. That leaves free cash flow at approximately $6.6 million or around 77% of our adjusted EBITDA. So cash conversion for the quarter came in better than our 70% annual target level. The primary use of cash we generate continues to be a reduction of debt. We paid down $1.9 million of our term debt during the quarter and at the quarter end, we had a cash balance of $41.4 million and term debt of $19.6 million. Additionally, at the end of April, we paid down an additional $9.6 million of our term debt. That left an outstanding term debt balance at April 30 of $10 million. Our balance sheet is strong and the business is expected to continue to yield free cash flow. Subsequent to our quarter end, we also negotiated an amendment to our existing credit agreement with Wintrust. The new amendment extinguished our term debt and expanded our $25 million revolver to $50 million. So coupled with our free cash flow, we believe we have ample capital to pursue our acquisition program without needing to turn to equity financing. Lastly, we have had a few inquiries regarding the remaining $15 sponsor warrants and the $12.50 merger warrants. As of May 5, approximately 160,000 warrants have been exercised, all on a cashless basis for approximately a net share issuance of 26,000 shares. As a reminder, both of the remaining tranches of warrants expire in July of 2023. I'll now hand the call back to Mike.